Scientists have long known of a link between loss of smell and dementia — mainly because the plaque buildup that signals ...

Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025 ...

New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...

Scientists have been developing and refining methods to accurately measure the age and health of our brains, without cutting ...

New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...

New research warns that blood tests for Alzheimer’s disease may be unreliable, particularly for Black patients. A recent ...

Alzheimer's blood tests show accuracy gaps across populations, raising concerns about reliable diagnosis and healthcare inequality.

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Federally funded research at Johns Hopkins offers new avenues for detecting brain disease long before it strikes ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...